Efficacy of Pembrolizumab and Olaparib Combination Observed in a Subset of Patients with HRD Metastatic Pancreatic Cancer By Ogkologos - April 7, 2026 296 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the POLAR study Source RELATED ARTICLESMORE FROM AUTHOR Giredestrant plus everolimus prolongs PFS among patients with ER-positive, HER2-negative, ESR1-mutated advanced breast cancer after the receipt of a CDK4/6 inhibitor EMA Recommends Granting a Marketing Authorisation for Ensartinib Taking on the RAS Challenge MOST POPULAR Diving into our role in 50 top cancer drugs February 9, 2022 Tagraxofusp Proves Effective for BPDCN, A Rare Blood Cancer May 15, 2019 Jennifer Garner Shared A Video Of Her Mammogram Appointment October 21, 2019 EMA Adopts Positive Opinion for Pemetrexed Baxter November 3, 2022 Load more HOT NEWS Keeping A Jasmine Plant In Your Room Reduces Anxiety, Panic Attacks... Using Integrative Therapies to Help Manage Cancer-Related Pain: An Expert Q&A Surgical Technique Helps Keep Breast Cancer Patients from Going Under the... EMA Recommends Granting a Marketing Authorisation for Tucatinib
